Amgen (AMGN) is known for its work in human therapeutics. Historically, some of Amgen's most successful drugs have been used to treat low white blood cell counts, osteoporosis, and colorectal cancer. Personally, I am getting to the age when I may have to start thinking about researching some of them.
More from Investing
We're in a chop-fest, and not only are stocks stuck in either/or mode, so are the indicators.
After Tuesday's rotational moves, Wednesday was choppy. Here's why this is not a time to make long-term trades.
The stock is ready to make a recovery rally.
Let's see where investors can go long on SPOT, according to my read of the charts.
DIS has been no day in the park for investors -- in fact, it's been acting more than a little Goofy lately. But I see this ride down starting to turn.